XML 20 R4.htm IDEA: XBRL DOCUMENT v3.6.0.2
Consolidated Balance Sheets - USD ($)
$ in Millions
Dec. 31, 2016
Dec. 31, 2015
Current Assets:    
Cash and cash equivalents $ 634.1 $ 1,459.3
Short-term investments   164.6
Accounts receivable, less allowance for doubtful accounts 1,604.4 1,446.5
Inventories 1,959.4 2,254.1
Prepaid expenses and other current assets 465.7 529.2
Total Current Assets 4,663.6 5,853.7
Property, plant and equipment, net 2,037.9 2,062.6
Goodwill 10,643.9 9,934.2
Intangible assets, net 8,785.4 8,746.3
Other assets 553.6 563.8
Total Assets 26,684.4 27,160.6
Current Liabilities:    
Accounts payable 364.5 284.8
Income taxes payable 183.5 147.2
Other current liabilities 1,257.9 1,185.9
Current portion of long-term debt 575.6  
Total Current Liabilities 2,381.5 1,617.9
Deferred income taxes 3,030.9 3,150.2
Other long-term liabilities 936.3 1,005.7
Long-term debt 10,665.8 11,497.4
Total Liabilities 17,014.5 17,271.2
Commitments and Contingencies (Note 20)
Stockholders' Equity:    
Common stock, $0.01 par value, one billion shares authorized, 304.7 million (302.7 million in 2015) issued 3.1 3.0
Paid-in capital 8,368.5 8,195.3
Retained earnings 8,467.1 8,347.7
Accumulated other comprehensive loss (434.0) (329.0)
Treasury stock, 104.1 million shares (100.0 million shares in 2015) (6,735.8) (6,329.1)
Total Zimmer Biomet Holdings, Inc. stockholders' equity 9,668.9 9,887.9
Noncontrolling interest 1.0 1.5
Total Stockholders' Equity 9,669.9 9,889.4
Total Liabilities and Stockholders' Equity $ 26,684.4 $ 27,160.6